X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
schizophrenia (519) 519
psychiatry (384) 384
humans (367) 367
index medicus (334) 334
schizophrenia - drug therapy (272) 272
antipsychotic agents - administration & dosage (233) 233
pharmacology & pharmacy (225) 225
male (213) 213
female (202) 202
adult (201) 201
antipsychotic agents - therapeutic use (198) 198
risperidone (175) 175
double-blind (153) 153
middle aged (152) 152
efficacy (147) 147
safety (142) 142
antipsychotic agents - adverse effects (140) 140
delayed-action preparations (139) 139
paliperidone palmitate (129) 129
long-acting injectable (124) 124
injectable risperidone (122) 122
risperidone - administration & dosage (115) 115
clinical neurology (112) 112
psychotropic drugs (111) 111
relapse (107) 107
antipsychotic drugs (104) 104
treatment outcome (103) 103
antipsychotics (102) 102
adherence (101) 101
injections, intramuscular (101) 101
risperidone - therapeutic use (90) 90
acting injectable risperidone (87) 87
neurosciences (86) 86
schizoaffective disorder (84) 84
drug therapy (83) 83
atypical antipsychotics (82) 82
injections (81) 81
maintenance treatment (80) 80
open-label (79) 79
antipsychotic (78) 78
long-acting injectable antipsychotics (77) 77
medication (74) 74
administration, oral (72) 72
oral antipsychotics (72) 72
psychosis (71) 71
adolescent (69) 69
patients (68) 68
aged (67) 67
mental disorders (67) 67
psychotic disorders - drug therapy (66) 66
aripiprazole (65) 65
risperidone - adverse effects (65) 65
depot (63) 63
medication adherence (63) 63
hospitalization (62) 62
young adult (62) 62
patient compliance (61) 61
drug administration schedule (58) 58
psychiatric status rating scales (58) 58
1st-episode schizophrenia (56) 56
acting injectable antipsychotics (56) 56
original research (56) 56
care and treatment (55) 55
bipolar disorder (54) 54
pharmacokinetics (54) 54
tolerability (53) 53
analysis (52) 52
schizophrenic psychology (52) 52
medicine, general & internal (51) 51
delayed-action preparations - administration & dosage (50) 50
drugs (50) 50
olanzapine (50) 50
quality of life (50) 50
neuroleptics (49) 49
depot antipsychotics (48) 48
haloperidol (48) 48
delayed-action preparations - therapeutic use (46) 46
injection (44) 44
1st episode (43) 43
quality-of-life (42) 42
studies (42) 42
nonadherence (40) 40
time factors (39) 39
retrospective studies (38) 38
antipsychotic agents - pharmacokinetics (37) 37
schizophrenia - diagnosis (37) 37
antipsychotic agents - economics (35) 35
prevention (35) 35
clinical trials (34) 34
medical research (34) 34
research (34) 34
dose-response relationship, drug (33) 33
injectable antipsychotics (33) 33
medicine, research & experimental (33) 33
double-blind method (32) 32
follow-up (32) 32
medicine, experimental (32) 32
paliperidone palmitate - administration & dosage (32) 32
antipsychotic agents - pharmacology (31) 31
medicine & public health (31) 31
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (642) 642
French (34) 34
German (7) 7
Polish (3) 3
Spanish (2) 2
Czech (1) 1
Dutch (1) 1
Italian (1) 1
Japanese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacokinetics, ISSN 0312-5963, 12/2018, Volume 57, Issue 12, pp. 1493 - 1528
Therapeutic drug monitoring studies have generally concentrated on controlling compliance and avoiding side effects by maintaining long-term exposure to... 
PERFORMANCE LIQUID-CHROMATOGRAPHY | OLANZAPINE PLASMA-CONCENTRATIONS | PALIPERIDONE EXTENDED-RELEASE | MULTIPLE-DOSE PHARMACOKINETICS | SERUM CONCENTRATIONS | SCHIZOPHRENIC-PATIENTS | LONG-TERM SAFETY | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | ACTING INJECTABLE RISPERIDONE | DOPAMINE-D-2 RECEPTOR OCCUPANCY
Journal Article
EXCLI Journal, ISSN 1611-2156, 10/2014, Volume 13, pp. 1163 - 1191
This review will concentrate on the clinical pharmacology, in particular pharmacodynamic data, related to atypical antipsychotics, clozapine, risperidone,... 
OLANZAPINE PLASMA-CONCENTRATIONS | REFRACTORY SCHIZOPHRENIC-PATIENTS | POSITRON-EMISSION-TOMOGRAPHY | INTRAMUSCULAR OLANZAPINE | BIOLOGY | DOUBLE-BLIND | SCHIZOAFFECTIVE DISORDER | 5-HT2 RECEPTOR OCCUPANCY | ACTING INJECTABLE RISPERIDONE | MAJOR DEPRESSIVE DISORDER | LONG-TERM TREATMENT
Journal Article
Journal Article
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, ISSN 0271-0749, 09/2019, Volume 39, Issue 5, pp. 494 - 498
Purpose/Background Long-acting injectable antipsychotics (LAIAs) are used in the management of schizophrenia, bipolar disorder, and related psychiatric... 
MEDICATION | long-acting injectable | drug use evaluation | PSYCHIATRY | pharmacotherapy | SCHIZOPHRENIA | PHARMACOLOGY & PHARMACY | antipsychotic
Journal Article
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, ISSN 0271-0749, 09/2019, Volume 39, Issue 5, pp. 441 - 445
Purpose Mirror-image studies, which compare equal periods of time before and after a new treatment is introduced, may reflect the real-world impact of that... 
PALIPERIDONE PALMITATE | oral antipsychotics | MAINTENANCE TREATMENT | MEDICATIONS | PSYCHIATRY | PREVENTION | RISPERIDONE | schizophrenia | DISCONTINUATION | mirror-image study | long-acting injectable antipsychotics | PHARMACOLOGY & PHARMACY | HALOPERIDOL DECANOATE
Journal Article
Criminal Justice Policy Review, ISSN 0887-4034, 5/2013, Volume 58, Issue 5_suppl, pp. 5 - 13
Journal Article